A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes

Conditions:   Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia Interventions:   Drug: abaloparatide;   Drug: bevacizumab Sponsor:   University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials